[ad_1]
Wegovy injection pens organized in Waterbury, Vermont, US, on Monday, April 28, 2025.
Shelby Knowles | Bloomberg | Getty Photos
Danish pharmaceutical large Novo Nordisk on Wednesday introduced plans to chop roughly 9,000 roles.
“Novo Nordisk right now introduced a company-wide transformation to simplify its organisation, enhance the pace of decision-making, and reallocate assets in the direction of the corporate’s progress alternatives in diabetes and weight problems,” the corporate, which produces the Wegovy weight reduction treatment, mentioned in a press release,
“As a part of the transformation, Novo Nordisk intends to cut back the worldwide workforce by roughly 9,000 of the 78,400 positions within the firm, with round 5,000 reductions anticipated in Denmark.”
This can be a creating story and shall be up to date shortly.
[ad_2]
